Drug · DIN 02398869
INDAYO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 8, 2026; first marketed September 1, 2016.
- Drug Identification Number (DIN)
- 02398869
- Company (DIN owner)
- Senador Laboratories Private LimitedHyderabad, Telangana, India
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Levonorgestrel and estrogen G03AA07
- Class
- Human
- Record last updated
- July 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVONORGESTREL | 0.15 MG | |
| ETHINYL ESTRADIOL | 0.03 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 8, 2026: NOC 37878Abbreviated New Drug Submission (ANDS) · Administrative: Change in product ownership
- March 24, 2016: NOC 17934Abbreviated New Drug Submission (ANDS) · Transfer of drug identification number
- September 11, 2015: NOC 17270Abbreviated New Drug Submission (ANDS) · Manufacturer name change
- June 2, 2015: NOC 16983Abbreviated New Drug Submission (ANDS)